lymphoma, b cell
Showing 1 - 6 of 6
Lymphoma, B Cell Trial in Changzhou (IL-2 pre-treated CD19 cells, IL-7/IL-15 pre-treated CD19 cells)
Unknown status
- Lymphoma, B Cell
- IL-2 pre-treated CD19 cells
- IL-7/IL-15 pre-treated CD19 cells
-
Changzhou, Jiangsu, ChinaFirst People's Hospital of Changzhou
Dec 12, 2016
Lymphoma, B Cell Trial (intrathecal rituximab)
Withdrawn
- Lymphoma, B Cell
- intrathecal rituximab
- (no location specified)
Mar 27, 2015
Lymphoma, B Cell Trial in Bellinzona (high dose methotrexate, high dose cytarabine, radiotherapy)
Completed
- Lymphoma, B Cell
- high dose methotrexate
- +2 more
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland (IOSI)
Mar 27, 2015
Neoplastic Meningitis, Lymphoma, B Cell Trial in Durham (cytarabine liposome injection)
Terminated
- Neoplastic Meningitis
- Lymphoma, B Cell
- cytarabine liposome injection
-
Durham, North CarolinaDuke University Medical Center
Jun 7, 2013
Lymphoma, B Cell Trial in Bellinzona (rituximab, CHOP, intrathecal methotrexate)
Completed
- Lymphoma, B Cell
- rituximab
- +3 more
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland (IOSI)
Jul 21, 2009